Navidea Biopharmaceuticals, Inc. (NAVB) earnings
Quarterly and annual NAVB reports and results, each read against the price at its own news timestamp. Back to the NAVB overview →
1 measured NAVB earnings event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q NAVIDEA BIOPHARMACEUTICA For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -0.40% |
Keep exploring
More NAVB: analyst actions → · SEC filings → · NAVB overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| OTSUKA HOLDINGS CO ADR (OTSKY) | 45 | -0.06% | 39% |
| Cipher Pharmaceuticals Inc (CPH_TSE) | 43 | -0.35% | 43% |
| POLYDEX PHARMS LTD (POLXF) | 43 | 0.00% | 35% |
| TERUMO CORP UNSP/ADR (TRUMY) | 43 | +0.14% | 61% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.